ATE316097T1 - Peptide mit antibakterieller wirkung - Google Patents

Peptide mit antibakterieller wirkung

Info

Publication number
ATE316097T1
ATE316097T1 AT01903165T AT01903165T ATE316097T1 AT E316097 T1 ATE316097 T1 AT E316097T1 AT 01903165 T AT01903165 T AT 01903165T AT 01903165 T AT01903165 T AT 01903165T AT E316097 T1 ATE316097 T1 AT E316097T1
Authority
AT
Austria
Prior art keywords
inhibiting
peptides
antibacterial effects
endotoxemia
tnf
Prior art date
Application number
AT01903165T
Other languages
English (en)
Inventor
Kevin H Mayo
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Application granted granted Critical
Publication of ATE316097T1 publication Critical patent/ATE316097T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT01903165T 2000-01-20 2001-01-19 Peptide mit antibakterieller wirkung ATE316097T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17725500P 2000-01-20 2000-01-20
US21029700P 2000-06-08 2000-06-08

Publications (1)

Publication Number Publication Date
ATE316097T1 true ATE316097T1 (de) 2006-02-15

Family

ID=26873090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01903165T ATE316097T1 (de) 2000-01-20 2001-01-19 Peptide mit antibakterieller wirkung

Country Status (8)

Country Link
US (1) US7144982B2 (de)
EP (1) EP1252181B1 (de)
AT (1) ATE316097T1 (de)
AU (1) AU2001231016A1 (de)
CA (1) CA2397835A1 (de)
DE (1) DE60116733T2 (de)
ES (1) ES2252187T3 (de)
WO (1) WO2001053335A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2255865C (en) * 1996-05-24 2008-10-14 The Regents Of The University Of Minnesota Synthesis of soluble beta-sheet forming peptides
EP1252181B1 (de) 2000-01-20 2006-01-18 Regents Of The University Of Minnesota Peptide mit antibakterieller wirkung
AU2003211163A1 (en) 2002-02-20 2003-09-09 Regents Of The University Of Minnesota Partial peptide mimetics and methods
EP1380290A1 (de) 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
CN1711074B (zh) * 2002-11-15 2010-10-06 尼普洛株式会社 脂质体
EP1581644B1 (de) * 2003-01-09 2007-06-06 Genentech, Inc. Reinigung von polypeptiden
WO2005009457A1 (en) * 2003-05-15 2005-02-03 Sangstat Medical Corporation Rdp58 compositions and methods for inhibiting vascularization of cell populations
JP2007512234A (ja) * 2003-10-17 2007-05-17 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 治療活性を有する修飾ポリペプチド及びその使用方法
DE602005012575D1 (en) * 2004-03-17 2009-03-19 Aplagen Gmbh Isostere transformation
ATE536177T1 (de) * 2004-10-04 2011-12-15 Univ Minnesota Calixaren-basierte peptidkonformationsmimetika, verfahren zu ihrer verwendung und verfahren zu ihrer herstellung
AU2006267176A1 (en) 2005-07-13 2007-01-18 Crossbeta Biosciences B.V. Cross-beta structure binding compounds
US8114832B2 (en) 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
US10611799B2 (en) * 2017-03-03 2020-04-07 National Tsing Hua University Anti-endotoxin polypeptide
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5595887A (en) 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US5348942A (en) 1993-03-12 1994-09-20 Xoma Corporation Therapeutic uses of bactericidal/permeability increasing protein products
US5447913A (en) 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
US5786324A (en) * 1994-03-24 1998-07-28 Regents Of The University Of Minnesota Synthetic peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
US5830860A (en) 1994-03-24 1998-11-03 Regents Of The University Of Minnesota Peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
US5955577A (en) 1996-06-27 1999-09-21 Regents Of The University Of Minnesota Method for synthesizing a water-soluble β-sheet forming peptide
CA2273186A1 (en) 1997-10-07 1999-04-15 New England Medical Center Hospitals, Inc. Structure-based rational design of compounds to inhibit papillomavirus infection
JP4037525B2 (ja) 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
EP1252181B1 (de) 2000-01-20 2006-01-18 Regents Of The University Of Minnesota Peptide mit antibakterieller wirkung

Also Published As

Publication number Publication date
US20020146406A1 (en) 2002-10-10
DE60116733T2 (de) 2006-11-02
AU2001231016A1 (en) 2001-07-31
EP1252181B1 (de) 2006-01-18
ES2252187T3 (es) 2006-05-16
DE60116733D1 (de) 2006-04-06
CA2397835A1 (en) 2001-07-26
WO2001053335A3 (en) 2001-12-13
WO2001053335A9 (en) 2002-10-31
EP1252181A2 (de) 2002-10-30
WO2001053335A2 (en) 2001-07-26
US7144982B2 (en) 2006-12-05

Similar Documents

Publication Publication Date Title
ATE316097T1 (de) Peptide mit antibakterieller wirkung
ES2160335T3 (es) Polimeros reticulables.
NO973933D0 (no) Vaskulær endotelvekstfaktor B
ATE421973T1 (de) Inzektizide proteinen von bacillus thuringiensis
ATE196475T1 (de) Auf histatin basierende, gegen pilze und bakterien gerichtete peptide
ATE427116T1 (de) Behandlung von bakteriellen infektionen
WO2002028902A3 (en) Nectin polypeptides, polynucleotides, methods of making and use thereof
EP2301563A3 (de) HSP20 Peptide
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
WO2004047771A3 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
DE60034879T8 (de) Lantibiotikum
DE60025026D1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
AU7980300A (en) Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics
WO2003087353A3 (en) Purified polypeptides involved in membrane biogenesis
DE50206480D1 (de) Antimikrobiell wirkendes peptid
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
DE60313786D1 (de) Poly(ethylen glykol)-konjugate von insulinähnlichem wachstumfaktor bindenden protein-4
AU2001244286A1 (en) Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof
AU2003239184A8 (en) Treatment and inhibition of ocular infections and wounds by cap37 and cap37 peptides
WO2001045738A3 (en) Use of heat shock proteins to enhance production of chemokines by a cell
WO2002000686A3 (en) Bioelastomer nanomachines and biosensors
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
AU2001230243A1 (en) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
EP1177203A4 (de) Kollagen-bindende proteine von enterococcalen bakterien

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties